Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
C2 Pharma
CAI
DPS Group
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CDMO
600 Articles Available
1
25
Can't find what you're looking for? Try our
advanced search
.
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
PR-M09-22-06
Leadership
Wheeler Bio Announces Roger Lias, Ph.D. as President and Chief Operating Officer
PR-M09-22-05
Business Leadership
Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
PR-M09-22-04
Biodefense
Supporting Biodefense Countermeasures with Strong Capabilities and Expertise
PAO-09-022-CL-03
Speed to Clinic
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
PAO-09-022-CL-04
CDMO
Asymchem: Leading with Technology
PAO-09-022-CL-01
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
PR-M09-22-01
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
PR-M07-22-03
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
PAO-06-022--NI-12
Animal Health
Gaining Insights into the Challenges, Trends, and Needs of Animal Health Organizations
PAO-06-022-CL-10
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
PR-M06-22-02
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
PAO-06-022-CL-04
Digitalization
Reducing Time to IND, Increasing Quality, and Building Trust through Shared Data
PAO-05-022-CL-01
Award
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award
PR-M05-22-12
OSD and Liquid
Reshoring Manufacturing and Targeted, Specialty Medicines
PAO-05-22-R250-05
Capacity Expansion
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients
PR-M05-22-05
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
PR-M04-22-14
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
PR-M04-22-12
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
PAO-04-022-CL-02
Lab Benchmarking
Top Results for Vetter in University of St. Gallen Benchmarking
PR-M04-22-04
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
PR-M04-22-01
Facility Expansion
Alcami Expands Biopharma Storage at Masy BioServices
PR-M03-22-15
Strategic Alliance
Rentschler Biopharma and Vetter Unveil Xpert Alliance
PR-M03-22-14
GMP Certification
GMP Certification for Exothera Further Extends its Viral Vector Manufacturing Capacity
PR-M03-22-10
1
25
»
